What is Apogee Therapeutics, Inc.'s common stock?

Apogee Therapeutics, Inc. (APGE) reported common stock of $1K in Q1 2026.

How has Apogee Therapeutics, Inc.'s common stock changed year-over-year?

Apogee Therapeutics, Inc.'s common stock decreased by 0.0% year-over-year, from $1K to $1K.

What does common stock mean?

The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Apogee Therapeutics, Inc. APGE Common Stock

Common Stock at other companies

Eli LillyLLY

$590M-0.4%

AbbVieABBV

$18M0.0%

Summit TherapeuticsSMMT

1B0.0%

Arrowhead ResearchARWR

$236K+2.6%

Immunovant, Inc.IMVT

——

Protagonist TherapeuticsPTGX

——

Other financials

Income statement

See full

Operating income-$82.8M-31.2%

Net income-$74.1M-33.9%

EPS (diluted)-$1.06-11.6%

Balance sheet

See full

Cash & equivalents$451.8M+323%

Total debt$8.0M-31.9%

Total assets$1.3B+81.1%

Cash flow

See full

Operating cash flow-$55.6M-14.6%

CapEx$62.0K—

Free cash flow-$62.8M+7.3%

Valuation

See full

Market cap$6.81B+189%

Enterprise value$6.37B+181%

Returns & leverage

See full

Current ratio32.6×+16.8×

Where this comes from

Reported directly by Apogee Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Apogee Therapeutics, Inc.'s common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Apogee Therapeutics, Inc.'s common stock?: Apogee Therapeutics, Inc. (APGE) reported common stock of $1K in Q1 2026.
How has Apogee Therapeutics, Inc.'s common stock changed year-over-year?: Apogee Therapeutics, Inc.'s common stock decreased by 0.0% year-over-year, from $1K to $1K.
What does common stock mean?: The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).